alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.25  Confidential materials
omitted and filed separately with the Securities and Exchange Commission.
Asterisks denote omissions.  Rider # 3 to the January 5, 1998 Agreement  ENTERED
INTO BETWEEN  LAssistance Publique Hôpitaux de Paris, public entity having its
registered head office 3, avenue Victoria, 75004 Paris RP, represented for the
present rider by Dèpartement de la Recherche Clinique et du Dèveloppement, Christophe Misse,
Directeur hereinafter referred to as AP-HP,  On the one hand,  AND  BiosSphère Medical S.A., company incorporated under n° B 418.584.033,
having its registered
head office 383 Rue de la Belle Etoile, 95700 Roissy-en-France,represented for the present rider by Richard J.
FALESCHINI, as Président Directeur Général, hereinafter referred to as BioSphère,  On the other hand,  AP-HP and BioSphère will be jointly referred to as the
Parties or, separately, Party.  PREAMBLE
:  (i)
  Pursuant to an agreement entered into on
  January 5, 1998 (the Agreement)
  amended by two riders dated February 10 and June 20, 2000, AP-HP
  and Biosepra, today Biosphère, have defined the conditions of the
  co-ownership of (i) a French patent filed on May 29, 1991 under n°
  91.06441 and (ii) its extensions worldwide (the Patents)
  and the rights and obligations of the Parties with respect to the commercial
  use of the Patents.(ii)
  The Agreement
  provides that BioSphère has the exclusive right to use the Patents during a
  10 year time period following the date when BioSphère was entitled to use the
  Patents. The Parties wish to renew this exclusive right for the whole
  duration of the Patents and of the products and specialties implementing the
  Patents as defined in the Agreement (the Products
  and Specialties).(iii)
  Under these
  circumstances, the Parties agreed to enter into this rider # 3 (the Rider).


THIS BEING SAID, THE PARTIES AGREE AS FOLLOWS :  ARTICLE 1  Article 5 of
the Agreement is amended as follows:  The Parties
agree that BioSphère is granted the rights relating to the Patents in view of
the exclusive use of the Products and Specialties of the Agreement worldwide,
for the whole duration of the Patents and of the Products and Specialties, and
for their use in the Domain of the Agreement.  ARTICLE 2  A paragraph (e) is
added to Article 8.1 of the Agreement.It reads as follows :  After the
expiration of the Patents, the rate of the royalties set forth in Articles 8.1(a) and
8.1(d) will amount to [**]%.The other provisions of these articles remain unchaged.  ARTICLE 3  The other articles of the Agreement and the two riders
dated February 10 and June 20, 2000 remain unchanged.  In                                     ,  On                                    ,  In three (3) counterparts,   AP-HP
  
  BioSphèreRichard J.
  Faleschini,Dèpartement de la Recherche Clinique et du Dèveloppement
  
  Président
  Directeur Général/s/ Christophe Misse
  
  /s/ Richard J. FaleschiniChristophe MisseDirecteurVisa of the financial
  controllerMr. Jean
  PARMENTIERPar delegation/s/ Norbert TournegrosNorbert TournegrosChargè de mission  2
Desmond BAKER, Petitioner, v. FLORIDA.

No. 19-7799.

Supreme Court of the United States.

June 1, 2020

Petition for writ of certiorari to the District Court of Appeal of Florida, Second District denied.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                             836
<SECURITIES>                                       121
<RECEIVABLES>                                    4,245
<ALLOWANCES>                                       155
<INVENTORY>                                         34
<CURRENT-ASSETS>                                 5,465
<PP&E>                                           2,155
<DEPRECIATION>                                   1,151
<TOTAL-ASSETS>                                   7,693
<CURRENT-LIABILITIES>                            2,467
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          4
<COMMON>                                           298
<OTHER-SE>                                       4,183
<TOTAL-LIABILITY-AND-EQUITY>                     7,693
<SALES>                                          2,794
<TOTAL-REVENUES>                                 3,493
<CGS>                                              446
<TOTAL-COSTS>                                    3,755
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   7
<INCOME-PRETAX>                                  (705)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (705)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (705)
<EPS-BASIC>                                     (0.05)
<EPS-DILUTED>                                   (0.05)


</TABLE>
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 24 Introduced in House (IH)]

113th CONGRESS
  1st Session
H. J. RES. 24

Proposing a balanced budget amendment to the Constitution of the United 
                                States.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 6, 2013

 Mr. Amash (for himself, Mr. Bentivolio, Mr. Bucshon, Mr. Chabot, Mr. 
 Culberson, Mr. Duncan of South Carolina, Mr. Gardner, Mr. Gosar, Mr. 
   Gowdy, Mr. Harris, Mr. Huelskamp, Mr. Hultgren, Mr. Labrador, Mr. 
  LaMalfa, Mr. Lamborn, Mr. Lipinski, Mr. Loebsack, Mrs. Lummis, Mr. 
    Massie, Mr. Michaud, Mr. Mulvaney, Mr. Palazzo, Mr. Pearce, Mr. 
   Quigley, Mr. Ribble, Mr. Rokita, Mr. Austin Scott of Georgia, Mr. 
 Stutzman, and Mr. Walberg) introduced the following joint resolution; 
          which was referred to the Committee on the Judiciary

_______________________________________________________________________

                            JOINT RESOLUTION

 
Proposing a balanced budget amendment to the Constitution of the United 
                                States.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled   (two-thirds of each House 
concurring therein), That the following article is proposed as an 
amendment to the Constitution of the United States, which shall be 
valid to all intents and purposes as part of the Constitution when 
ratified by the legislatures of three-fourths of the several States 
within seven years after the date of its submission for ratification:

                              ``Article--

    ``Section 1. Total outlays for a year shall not exceed the average 
annual revenue collected in the three prior years, adjusted in 
proportion to changes in population and inflation. Total outlays shall 
include all outlays of the United States except those for payment of 
debt, and revenue shall include all revenue of the United States except 
that derived from borrowing.
    ``Section 2. Congress may by a roll call vote of two-thirds of each 
House declare an emergency and provide by law for specific outlays in 
excess of the limit in section 1. The declaration shall specify reasons 
for the emergency designation and may authorize outlays in excess of 
the limit in section 1 for up to one year.
    ``Section 3. Congress shall have power to enforce this article by 
appropriate legislation.
    ``Section 4. This article shall take effect in the first year 
beginning at least 90 days following ratification, except that outlays 
may exceed the limit in section 1 by the following portion of the prior 
year's outlays exceeding that limit (excepting emergency outlays 
provided for by section 2): nine-tenths in the first year, eight-ninths 
in the second, seven-eighths in the third, six-sevenths in the fourth, 
five-sixths in the fifth, four-fifths in the sixth, three-fourths in 
the seventh, two-thirds in the eighth, and one-half in the ninth.''.
                                 <all>
```
[Federal Register Volume 87, Number 110 (Wednesday, June 8, 2022)]
[Notices]
[Page 34893]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-12298]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Heart, Lung, and Blood Initial Review Group; 
NHLBI Institutional Training Mechanism Study Section.
    Date: June 2-3, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Michael Reilly Ph.D., Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, 6705 Rockledge Drive, Room 208-Z, Bethesda, MD 20892, 
301-827-7975, <a href="/cdn-cgi/l/email-protection#304255595c5c495d40705e585c52591e5e59581e575f46"><span class="__cf_email__" data-cfemail="3547505c59594c5845755b5d59575c1b5b5c5d1b525a43">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: June 2, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-12298 Filed 6-7-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
```

```

----

Updated May 2, 2014
NO. 01-15-00775-CV

IN THE COURT OF APPEALS FOR THE FIRST DISTRICT OF TEXAS HOUSTON, TEXAS

Adriene Sibley, Appellant

v. Seminole Pipeline Company, LLC, Enterprise Products Operating, LLC, First Call Field Service Corp., and TDW Services, Inc. Appellees

TDW SERVICES, INC.'S ENTRY OF APPEARANCE OFAPPELLATECOUNSEL

TO THE HONORABLE COURT OF APPEALS: Barry Abrams and Marquel S. Jordan ofthe law firm Blank Rome, LLP, hereby enter their appearance as appellate counsel on behalfofAppellee TDW Services, Inc. The undersigned counsel respectfully request that all pleadings, notices, and correspondence in this matter be forwarded to their attention at the address below.

145431.00601/101802041v.1 ACCEPTED 01-15-00775-CV FIRST COURT OF APPEALS

HOUSTON, TEXAS 12/16/2015 3:50:42 PM CHRISTOPHER PRINE

CLERK145431.00601/101802041v.1 Respectfully submitted, BLANK ROME LLP By:

## ~ 

## Sb.**~** 9'... Barry Abrams State Bar No. 00822700 Babrams@BlankRome.com Marquel S. Jordan State Bar No. 24041870 Mjordan@BlankRome.com 700 Louisiana, Suite 4000 Houston, Texas 77002 (713) 228-6601 (713) 228-6605 (fax) 

### Attorneys forAppellee TDWServices, Inc.

### CERTIFICATE OF SERVICE I certify that a true and correct copy ofthe foregoing Entry ofAppearance has been forwarded to the following parties through their counsel ofrecord on this l 61h day ofDecember, 2015. Adriene Sibley, Pro Se 4808 Fairmont Parkway Pasadena, Texas 77505 sibleyadriene@yahoo.com Thomas A. Zabel tzabel@zflawfirm.com James A. Freeman jfreeman@zflawfirm.com Zabel Freeman 420 Heights Blvd. Houston, TX 77007 Mr. Justin R. Gilbert justingilbert@gilbertfurey.com Gilbert & Furey 222 North Velasco Street Angleton, TX 77515

145431.00601/101802041 v.1

# ~~~ Marquel S. Jordan
James Gregory ARMISTEAD, Petitioner v. Laura P. WATSON, et al.

No. 19-5706

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
xml version="1.0" encoding="UTF-8"?


C\_2018388EN.01000901.xml


| | | | |
| --- | --- | --- | --- |
| 26.10.2018 | EN | Official Journal of the European Union | C 388/9 |

---

Prior notification of a concentration

(Case M.8492 — Quaker/Global Houghton)

(Text with EEA relevance)

(2018/C 388/10)

1.

On 19 October 2018, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2018388EN.01000901-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | Quaker Chemical Corporation (‘Quaker’, US), |

| | |
| --- | --- |
| — | Global Houghton Ltd (‘Houghton’, US), controlled by Gulf Houghton. |

Quaker acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of Houghton.

The concentration is accomplished by way of purchase of shares.

The same concentration was already notified to the Commission on 2 February 2018, but the notification was subsequently withdrawn on 16 March 2018.

2.

The business activities of the undertakings concerned are:

—   Quaker: active in the development and marketing of custom-formulated chemical specialty products. Quaker is a global provider of process fluids, chemical specialty products and technical expertise to a wide range of industries,

—   Houghton: active in the development, production and management of specialty chemicals, oils and lubricants. Houghton sells its products to a wide variety of industries.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.8492 — Quaker/Global Houghton

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| Email: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2018388EN.01000901-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

---
EXHIBIT 32.2



Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title
18, United States Code)



Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Reptron Electronics, Inc., Inc., a Florida corporation (the Company), does hereby certify that:



To my knowledge, the Annual Report on Form 10-K/A for the
year ended December 31, 2003 (the Form 10-K/A) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-K/A fairly presents, in all
material respects, the financial condition and results of operations of the Company.



|               |  |  |  |                                              
|-------------- |  |  |  | ---------------------------------------------
|               |  |  |  |                                              
|               |  | 
|April 29, 2004 |  |  |  | By: /s/ Paul J. Plante                       
|               |  |  |  |                                              
|Date           |  |  |  | Paul J. Plante Acting Chief Financial Officer



A signed original of
this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32.2


Written Statement of the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350


Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, the undersigned certifies that to the best of my knowledge:


(1) the Quarterly Report on Form 10-Q of A. O. Smith Corporation for the quarter ended June 30, 2023 (the "Report") fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and


(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of A. O. Smith Corporation.


July 28, 2023


/s/ Charles T. LauberCharles T. LauberExecutive Vice President and Chief Financial Officer
Cedric EDNEY, Petitioner, v. UNITED STATES.

No. 19-7965.

Supreme Court of the United States.

May 4, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
Jason L. BROWN, Petitioner, v. Lisa M. BROWN.

No. 19-7577.

Supreme Court of the United States.

April 20, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.
Ricky Daniel WAGONER, Petitioner v. NORTH CAROLINA.

No. 19-5121

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the Court of Appeals of North Carolina denied.
Salvatore MORETTI, Petitioner v. Michael MORDAGA

No. 19-5496

Supreme Court of the United States.

October 7, 2019

Motion of petitioner for leave to proceed *in forma pauperis* denied, and the petition for a writ of certiorari to the United States Court of Appeals for the Third Circuit dismissed. See Rule 39.8.

Justice Alito took no part in the consideration or decision of this motion and this petition.
Eric Jeffrey COWAN, Petitioner, v. Josie GASTELO, Warden.

No. 19-8141.

Supreme Court of the United States.

June 1, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
`DTCC Repo-US Treasury <30 YR - NYSE LIFFE - NYPC                     Code-045L2T
OPTION AND FUTURES COMBINED POSITIONS AS OF 09/03/13          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
(CONTRACTS OF $5,000,000)                            OPEN INTEREST:       31,534
COMMITMENTS
   2,123    3,554    2,039   27,300   25,853   31,462   31,446       72       88

CHANGES FROM 08/27/13 (CHANGE IN OPEN INTEREST:     -8,306)
    -647   -1,621     -567   -7,085   -6,049   -8,299   -8,237       -7      -69

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
     6.7     11.3      6.5     86.6     82.0     99.8     99.7      0.2      0.3

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:       35)
       9        6        6       15       15       25       26`

---

Updated September 6, 2013
James KING, Petitioner, v. Douglas BROWNBACK, et al.

No. 19-718.

Supreme Court of the United States.

March 30, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
H. Con. Res. 19 Agreed to March 21, 2013

One Hundred Thirteenth Congress 

of the 

United States of America 

AT THE FIRST SESSION 

Begun and held at the City of Washington on Thursday, 

the third day of January, two thousand and thirteen 

Concurrent Resolution 

Resolved by the House of Representatives (the Senate concurring), 

SECTION 1. USE OF CAPITOL GROUNDS FOR SOAP BOX DERBY RACES. 

(a) IN GENERAL.—The Greater Washington Soap Box Derby 

Association (in this resolution referred to as the ‘‘sponsor’’) shall 

be permitted to sponsor a public event, soap box derby races (in 

this resolution referred to as the ‘‘event’’), on the Capitol Grounds. 

(b) DATE OF EVENT.—The event shall be held on June 15, 

2013, or on such other date as the Speaker of the House of Representatives and the Committee on Rules and Administration of 

the Senate jointly designate. 

SEC. 2. TERMS AND CONDITIONS. 

(a) IN GENERAL.—Under conditions to be prescribed by the 

Architect of the Capitol and the Capitol Police Board, the event 

shall be— 

(1) free of admission charge and open to the public; and 

(2) arranged not to interfere with the needs of Congress. 

(b) EXPENSES AND LIABILITIES.—The sponsor shall assume full 

responsibility for all expenses and liabilities incident to all activities 

associated with the event. 

SEC. 3. EVENT PREPARATIONS. 

Subject to the approval of the Architect of the Capitol, the 

sponsor is authorized to erect upon the Capitol Grounds such stage, 

sound amplification devices, and other related structures and equipment as may be required for the event. 

SEC. 4. ADDITIONAL ARRANGEMENTS. 

The Architect of the Capitol and the Capitol Police Board 

are authorized to make such additional arrangements as may be 

required to carry out the event. 

SEC. 5. ENFORCEMENT OF RESTRICTIONS. 

The Capitol Police Board shall provide for enforcement of the 

restrictions contained in section 5104(c) of title 40, United States 

Code, concerning sales, advertisements, displays, and solicitations 
H. Con. Res. 19—2 

on the Capitol Grounds, as well as other restrictions applicable 

to the Capitol Grounds, with respect to the event. 

Attest: 

Clerk of the House of Representatives. 

Attest: 

Secretary of the Senate.
President Relocation Benefits Letter



 Exhibit 10.5 

 

					
	 




	 		  	 13024 Ballantyne Corporate Place

	 		  	 Harris Building Suite 900

	 		  	 Charlotte, NC 28277

	 		  	 (704) 554-1421

	 		  	  
 April 9, 2012


 Mr. Carl E. Lee, Jr. 
 1250 York Street 
 Hanover, PA 17331 

Re: Relocation Benefits 
 The
purpose of this letter is to confirm the relocation benefits you are eligible to receive associated with your move from York, PA to Charlotte, NC in connection with your role as President and Chief Operating Officer at Snyder’s-Lance, Inc.

 You are entitled to the standard benefits that are provided to relocating employees as outlined below: 

 

	 	•	 	 House hunting & temporary lodging 


  

	 	•	 	 Approved miscellaneous relocation expenses 


  

	 	•	 	 Transportation of household goods 


  

	 	•	 	 Home sale marketing assistance 


  

	 	•	 	 Home purchase assistance 



In recognition of the current real estate market and the expectation of a loss on the sale of your current home, the Compensation Committee of the Board
of Directors have approved in lieu of your participation in the Company’s relocation relief fund, a payment of Two-Hundred and Fifty Thousand Dollars ($250,000.00) that will be made in cash to you following your purchase of a home in Charlotte,
NC. This payment will be made following the closing of the purchase transaction and will be subject to normal withholdings. 
  

	
	 Very truly yours,

	
	 David V. Singer

	 Chief Executive Officer